“Flexibility and the adjustable infrastructure of the IZB allowed us to grow from 6 to ­over 50 team members and, moreover, will support our further expansion.”

Michael Scholl, CEO, LEUKO­CARE AG

“Located in the IZB, at home in the world – from here we serve customers in 50 countries.”


The start-ups at the IZB

The Innovation and Start-up Centers Biotechno­logy (IZB) in Martinsried and Weihenstephan offer start-ups a creative environment in cutting-edge research at Martinsried Campus and Weihenstephan ­Campus. Entrepreneurs benefit from high-quality building infrastructure, flexibly designed office space and furnished laboratory units (S1 laboratories) at fair prices.

Successful companies that have emerged from the IZB include Medigene AG, Morphosys AG, Micromet GmbH (today Amgen Inc.), Octopharma GmbH, Corimmun GmbH (today Janssen-Cilag), Proteros GmbH, Coriolis Pharma Research GmbH, Rigontec GmbH (today MSD) and Exosome Diagnostics (today Bio-Techne) as well as the 4SC AG.

Start-ups currently based